Literature DB >> 22659292

Severe peritonitis induced by methotrexate during treatment of persistent gestational trophoblastic disease.

Stefan Zimmermann, Khalil Zaman, Anita Wolfer, William Jacot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22659292      PMCID： PMC3425533          DOI： 10.1634/theoncologist.2012-0146

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  6 in total

1.  [Conservative treatment of ectopic pregnancies and presentation of a complicated case of peritonitis due to methotrexate].

Authors:  K C Eulgem; R Knitza
Journal:  Gynakol Geburtshilfliche Rundsch       Date:  2000

2.  Sclerosing encapsulating peritonitis and methotrexate.

Authors:  A Sachdev; V Usatoff; C Thaow
Journal:  Aust N Z J Obstet Gynaecol       Date:  2006-02       Impact factor: 2.100

3.  Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis.

Authors:  J R Lurain; L A Casanova; D S Miller; A W Rademaker
Journal:  Am J Obstet Gynecol       Date:  1991-02       Impact factor: 8.661

4.  Pleurisy and methotrexate treatment.

Authors:  P A Walden; P F Mitchell-Weggs; C Coppin; J Dent; K D Bagshawe
Journal:  Br Med J       Date:  1977-10-01

5.  Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.

Authors:  R S Berkowitz; D P Goldstein; M R Bernstein
Journal:  Gynecol Oncol       Date:  1990-01       Impact factor: 5.482

6.  Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.

Authors:  S Sharma; S Jagdev; R E Coleman; B W Hancock; P C Lorigan
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.